Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Hydrotherapy | Research article

The nature of rehabilitation services provided to children with cerebral palsy: a population-based nationwide study

Authors: Seong Woo Kim, Ha Ra Jeon, Taemi Youk, Jiyong Kim

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Cerebral palsy (CP) is a serious neurodevelopmental disorder that occurs in childhood and requires a range of treatments over a person’s lifetime. The aims of this study were to investigate the nature of the rehabilitation treatments provided to children with CP and to determine if there were any changes in patterns over time.

Methods

From 2003 to 2013, the nature of rehabilitation treatment was analyzed for children diagnosed with CP. In addition, the medical data of rehabilitation treatments over a 10-year period (from birth to nine years of age) were analyzed for children born in 2004 diagnosed with CP. Furthermore, we analyzed whether there was a difference in the costs of medical expenditures according to family income. All studies were based on data from the Korean National Health Information Database.

Results

It was found that, in recent years, rehabilitation therapy and spasticity treatment of children with CP have started being performed at a younger age than in the past. Among the children with CP born in 2004, 28.6% had physical therapy and 25.4% had occupational therapy on an inpatient basis; 81.3% had physical therapy and 62.2% had occupational therapy on an outpatient basis. Additionally, 22.2% of children received botulinum toxin injection therapy at least once. The numbers of children receiving rehabilitation therapy and botulinum toxin injection were highest at 1–5 years of age and 6–7 years of age, respectively. The expenditure on rehabilitation therapy was not affected by the economic level of the family.

Conclusion

This study investigated the nature of rehabilitation services provided to children with CP. More recently, the treatment of children with CP has started to be performed earlier than in the past. In addition, it was confirmed that the nature of rehabilitation treatment for children with CP changed according to age. Based on these results, services and health policies may need to be better organized to enhance the benefits to children with CP.
Literature
1.
go back to reference Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et al. Proposed definition and classification of cerebral palsy, april 2005. Dev Med Child Neurol. 2005;47(8):571–6. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et al. Proposed definition and classification of cerebral palsy, april 2005. Dev Med Child Neurol. 2005;47(8):571–6.
2.
go back to reference Vos RC, Becher JG, Ketelaar M, Smits DW, Voorman JM, Tan SS, et al. Developmental trajectories of daily activities in children and adolescents with cerebral palsy. Pediatrics. 2013;132(4):e915–23. Vos RC, Becher JG, Ketelaar M, Smits DW, Voorman JM, Tan SS, et al. Developmental trajectories of daily activities in children and adolescents with cerebral palsy. Pediatrics. 2013;132(4):e915–23.
3.
go back to reference Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, et al. A systematic review of interventions for children with cerebral palsy: State of the evidence. Dev Med Child Neurol. 2013;55(10):885–910. Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, et al. A systematic review of interventions for children with cerebral palsy: State of the evidence. Dev Med Child Neurol. 2013;55(10):885–910.
4.
go back to reference Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--united states, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57–9. Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--united states, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57–9.
5.
go back to reference Hoving MA, Evers SM, Ament AJ, van Raak EP, Vles JS, Dutch Group on Child Spasticity. Intractable spastic cerebral palsy in children: A dutch cost of illness study. Dev Med Child Neurol. 2007 May;49(5):397–8. Hoving MA, Evers SM, Ament AJ, van Raak EP, Vles JS, Dutch Group on Child Spasticity. Intractable spastic cerebral palsy in children: A dutch cost of illness study. Dev Med Child Neurol. 2007 May;49(5):397–8.
6.
go back to reference Park MS, Kim SJ, Chung CY, Kwon DG, Choi IH, Lee KM. Prevalence and lifetime healthcare cost of cerebral palsy in south korea. Health Policy. 2011;100(2-3):234–238. Park MS, Kim SJ, Chung CY, Kwon DG, Choi IH, Lee KM. Prevalence and lifetime healthcare cost of cerebral palsy in south korea. Health Policy. 2011;100(2-3):234–238.
7.
go back to reference Strickland BB, Jones JR, Ghandour RM, Kogan MD, Newacheck PW. The medical home: Health care access and impact for children and youth in the united states. Pediatrics. 2011;127(4):604–611. Strickland BB, Jones JR, Ghandour RM, Kogan MD, Newacheck PW. The medical home: Health care access and impact for children and youth in the united states. Pediatrics. 2011;127(4):604–611.
8.
go back to reference Schaible B, Colquitt G, Caciula M, Carnes A, Li L, Moreau N. Comparing impact on the family and insurance coverage in children with cerebral palsy and children with another special healthcare need. Child: care, health and development. 2018;44(3):370–377. Schaible B, Colquitt G, Caciula M, Carnes A, Li L, Moreau N. Comparing impact on the family and insurance coverage in children with cerebral palsy and children with another special healthcare need. Child: care, health and development. 2018;44(3):370–377.
9.
go back to reference McManus BM, Rapport MJ, Richardson Z, Lindrooth R. Therapy use for children with developmental conditions: Analysis of colorado medicaid data. Pediatr Phys Ther. 2017;29(3):192–198. McManus BM, Rapport MJ, Richardson Z, Lindrooth R. Therapy use for children with developmental conditions: Analysis of colorado medicaid data. Pediatr Phys Ther. 2017;29(3):192–198.
10.
go back to reference McManus BM, Prosser LA, Gannotti ME. Which children are not getting their needs for therapy or mobility aids met? data from the 2009–2010 national survey of children with special health care needs. Phys Ther. 2016;96(2):222–231. McManus BM, Prosser LA, Gannotti ME. Which children are not getting their needs for therapy or mobility aids met? data from the 2009–2010 national survey of children with special health care needs. Phys Ther. 2016;96(2):222–231.
12.
go back to reference Cheol Seong S, Kim Y, Khang Y, Heon Park J, Kang H, Lee H, et al. Data resource profile: The national health information database of the national health insurance service in south korea. Int J Epidemiol. 2016:dyw253. Cheol Seong S, Kim Y, Khang Y, Heon Park J, Kang H, Lee H, et al. Data resource profile: The national health information database of the national health insurance service in south korea. Int J Epidemiol. 2016:dyw253.
13.
go back to reference Chan G, Miller F. Assessment and treatment of children with cerebral palsy. Orthop Clin North Am. 2014;45(3):313–25. Chan G, Miller F. Assessment and treatment of children with cerebral palsy. Orthop Clin North Am. 2014;45(3):313–25.
14.
go back to reference Herskind A, Greisen G, Nielsen JB. Early identification and intervention in cerebral palsy. Dev Med Child Neurol. 2015;57(1):29–36. Herskind A, Greisen G, Nielsen JB. Early identification and intervention in cerebral palsy. Dev Med Child Neurol. 2015;57(1):29–36.
15.
go back to reference Hadders-Algra M. Early diagnosis and early intervention in cerebral palsy. Front Neurol. 2014;5:185. Hadders-Algra M. Early diagnosis and early intervention in cerebral palsy. Front Neurol. 2014;5:185.
16.
go back to reference Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: Much ado about nothing? Clin Neuropharmacol. 2009;32(4):213–8. Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: Much ado about nothing? Clin Neuropharmacol. 2009;32(4):213–8.
17.
go back to reference Majnemer A, Shikako-Thomas K, Lach L, Shevell M, Law M, Schmitz N, et al. Rehabilitation service utilization in children and youth with cerebral palsy. Child Care Health Dev. 2014;40(2):275-82. Majnemer A, Shikako-Thomas K, Lach L, Shevell M, Law M, Schmitz N, et al. Rehabilitation service utilization in children and youth with cerebral palsy. Child Care Health Dev. 2014;40(2):275-82.
Metadata
Title
The nature of rehabilitation services provided to children with cerebral palsy: a population-based nationwide study
Authors
Seong Woo Kim
Ha Ra Jeon
Taemi Youk
Jiyong Kim
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4111-4

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue